West Des Moines, IA1 Active Studies

Parkinsons Disease Clinical Trials in West Des Moines, IA

Find 1 actively recruiting parkinsons disease clinical trials in West Des Moines, IA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
642
Enrolling

Recruiting Parkinsons Disease Studies in West Des Moines

About Parkinsons Disease Clinical Trials in West Des Moines

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 1 parkinsons disease clinical trials recruiting participants in West Des Moines, IA. These studies are seeking a combined 642 participants. Research is being sponsored by Temple University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in West Des Moines — FAQ

Are there parkinsons disease clinical trials in West Des Moines?

Yes, there are 1 parkinsons disease clinical trials currently recruiting in West Des Moines, IA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in West Des Moines?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the West Des Moines research site will contact you about next steps.

Are clinical trials in West Des Moines free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many West Des Moines studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 1 active trials in West Des Moines are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 13, 2026 from ClinicalTrials.gov